Multivalent Glycosylated Nanostructures for Ebola Virus Infection
The infection of humans by lethal pathogens such as Ebola and other related viruses has not been properly addressed so far. In this context, a relevant question arises: what can chemistry do in the search for new strategies and approaches to solve this emergent problem? Although initially a variety...
| Autores: | , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2017 |
| País: | España |
| Institución: | Universidad Complutense de Madrid (UCM) |
| Repositorio: | Docta Complutense |
| Idioma: | inglés |
| OAI Identifier: | oai:docta.ucm.es:20.500.14352/18416 |
| Acceso en línea: | https://hdl.handle.net/20.500.14352/18416 |
| Access Level: | acceso abierto |
| Palabra clave: | 547 Química orgánica (Química) 2306 Química Orgánica |
| id |
ES_c502df8d407147dcb3bf8a7fb5710feb |
|---|---|
| oai_identifier_str |
oai:docta.ucm.es:20.500.14352/18416 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Multivalent Glycosylated Nanostructures for Ebola Virus InfectionIllescas Martínez, Beatriz MaríaRojo, JavierDelgado Vázquez, RafaelMartín León, Nazario547Química orgánica (Química)2306 Química OrgánicaThe infection of humans by lethal pathogens such as Ebola and other related viruses has not been properly addressed so far. In this context, a relevant question arises: what can chemistry do in the search for new strategies and approaches to solve this emergent problem? Although initially a variety of known chemical compounds – for other purposes – have been disappointingly tested against Ebola virus infection, more recently, specific molecules have been prepared. In this Perspective, we present a new approach directed to the design of efficient entry inhibitors to minimize the development of resistance by viral mutations. In particular, we focused on dendrimers as well as fullerene C60 – with a unique symmetrical and 3D globular structure – as biocompatible carbon platforms for the multivalent presentation of carbohydrates. The antiviral activity of these compounds in an Ebola pseudotyped infection model were in the low micromolar range for fullerenes with 12 and 36 mannoses. However, new tridecafullerenes – in which the central alkyne scaffold of [60]fullerene has been connected to 12 sugar-containing [60]fullerene units (total 120 mannoses)– exhibit an outstanding antiviral activity with IC50 in the subnanomolar range! The multivalent presentation of specific carbohydrates by using 3D fullerenes as controlled biocompatible carbon scaffolds represents a real advance being currently the most efficient molecules in vitro against Ebola virus infection. However, additional studies are needed to determine the optimized fullerene-based leads for practical applications.ACSUniversidad Complutense de Madrid20172017-01-0120172017-01-01journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/20.500.14352/18416reponame:Docta Complutenseinstname:Universidad Complutense de Madrid (UCM)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:docta.ucm.es:20.500.14352/184162026-06-02T12:44:21Z |
| dc.title.none.fl_str_mv |
Multivalent Glycosylated Nanostructures for Ebola Virus Infection |
| title |
Multivalent Glycosylated Nanostructures for Ebola Virus Infection |
| spellingShingle |
Multivalent Glycosylated Nanostructures for Ebola Virus Infection Illescas Martínez, Beatriz María 547 Química orgánica (Química) 2306 Química Orgánica |
| title_short |
Multivalent Glycosylated Nanostructures for Ebola Virus Infection |
| title_full |
Multivalent Glycosylated Nanostructures for Ebola Virus Infection |
| title_fullStr |
Multivalent Glycosylated Nanostructures for Ebola Virus Infection |
| title_full_unstemmed |
Multivalent Glycosylated Nanostructures for Ebola Virus Infection |
| title_sort |
Multivalent Glycosylated Nanostructures for Ebola Virus Infection |
| dc.creator.none.fl_str_mv |
Illescas Martínez, Beatriz María Rojo, Javier Delgado Vázquez, Rafael Martín León, Nazario |
| author |
Illescas Martínez, Beatriz María |
| author_facet |
Illescas Martínez, Beatriz María Rojo, Javier Delgado Vázquez, Rafael Martín León, Nazario |
| author_role |
author |
| author2 |
Rojo, Javier Delgado Vázquez, Rafael Martín León, Nazario |
| author2_role |
author author author |
| dc.contributor.none.fl_str_mv |
Universidad Complutense de Madrid |
| dc.subject.none.fl_str_mv |
547 Química orgánica (Química) 2306 Química Orgánica |
| topic |
547 Química orgánica (Química) 2306 Química Orgánica |
| description |
The infection of humans by lethal pathogens such as Ebola and other related viruses has not been properly addressed so far. In this context, a relevant question arises: what can chemistry do in the search for new strategies and approaches to solve this emergent problem? Although initially a variety of known chemical compounds – for other purposes – have been disappointingly tested against Ebola virus infection, more recently, specific molecules have been prepared. In this Perspective, we present a new approach directed to the design of efficient entry inhibitors to minimize the development of resistance by viral mutations. In particular, we focused on dendrimers as well as fullerene C60 – with a unique symmetrical and 3D globular structure – as biocompatible carbon platforms for the multivalent presentation of carbohydrates. The antiviral activity of these compounds in an Ebola pseudotyped infection model were in the low micromolar range for fullerenes with 12 and 36 mannoses. However, new tridecafullerenes – in which the central alkyne scaffold of [60]fullerene has been connected to 12 sugar-containing [60]fullerene units (total 120 mannoses)– exhibit an outstanding antiviral activity with IC50 in the subnanomolar range! The multivalent presentation of specific carbohydrates by using 3D fullerenes as controlled biocompatible carbon scaffolds represents a real advance being currently the most efficient molecules in vitro against Ebola virus infection. However, additional studies are needed to determine the optimized fullerene-based leads for practical applications. |
| publishDate |
2017 |
| dc.date.none.fl_str_mv |
2017 2017-01-01 2017 2017-01-01 |
| dc.type.none.fl_str_mv |
journal article http://purl.org/coar/resource_type/c_6501 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/20.500.14352/18416 |
| url |
https://hdl.handle.net/20.500.14352/18416 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
ACS |
| publisher.none.fl_str_mv |
ACS |
| dc.source.none.fl_str_mv |
reponame:Docta Complutense instname:Universidad Complutense de Madrid (UCM) |
| instname_str |
Universidad Complutense de Madrid (UCM) |
| reponame_str |
Docta Complutense |
| collection |
Docta Complutense |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869418951674429440 |
| score |
15,300719 |